Rare diseases
Investigational molecules
Locations
Back to Germany141 clinical trials in Nürnberg, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study Comparing Pembrolizumab and Placebo for Patients with Resected High-Risk Stage II Melanoma
GermanyStudy on the Safety and Effects of Forimtamig, Tocilizumab, and Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma
GermanyStudy Comparing Nivolumab to Placebo for Patients with High-Risk Invasive Bladder Cancer
GermanyStudy on Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Low-Risk Multiple Myeloma
GermanyStudy to Compare Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
GermanyStudy of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation
GermanyStudy of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
GermanyStudy on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction
GermanyStudy Comparing Docetaxel, Darolutamide, and ADT for Patients with Metastatic Hormone-Sensitive Prostate Cancer
GermanyEvaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk
GermanyStudy of Nivolumab, Ipilimumab, or Cabazitaxel for Men with Advanced Prostate Cancer Resistant to Hormone Therapy
GermanyStudy on Atezolizumab and Bevacizumab for Patients with Unresectable Liver Cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focused on treating multiple myeloma, breast cancer, and melanoma. Studies evaluate novel therapies including CAR T-cell treatments and targeted immunotherapies.
Advanced research includes investigation of new combination therapies and maintenance treatments post-transplantation.
Innovative research targeting atherosclerotic cardiovascular disease and related conditions. Trials evaluate new medications for managing cholesterol and reducing major cardiovascular events.
Focus on developing treatments to improve patient outcomes in cardiovascular conditions.
Clinical studies examining treatments for inflammatory myopathies and psoriatic arthritis. Research focuses on innovative therapies and disease management approaches.
Emphasis on developing targeted treatments for severe inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
